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Abstract Objective Hypertension induces coronary
artery disease (CAD) and progression of arterial wall
calcification. As coronary calcifications may cause
artefacts in 64-slice computed tomography coronary
angiography (CTCA), we sought to determine the
diagnostic accuracy of CTCA in patients with and
without arterial hypertension. Methods Eighty-five
consecutive patients with suspected CAD underwent
CTCA, calcium-scoring and conventional coronary
angiography, and were grouped as hypertensive
(28 women, 31 men, mean age 65 ± 9 years, age range
49–82 years) or normotensive patients (10 women, 16
men, mean age 62 ± 11 years, age range 39–77 years).
On an intention-to-diagnose-basis, no coronary segment
was excluded and non-evaluative segments were rated
as false positive. Results Per-patient sensitivity, speci-
ficity, positive predictive value (PPV), and negative
predictive value (NPV) in the hypertensive group were
91.4, 83.3, 88.9, and 86.9%, while the respective values
in the normotensive group were 100, 78.9, 63.6, and
100% (P = 0.42, 0.71, 0.05, and 0.15). In the hyper-
tensive group the prevalence of CAD was 59% and the
mean calcium-score was 256; respective values in the
normotensive group were 27% and 69, (P \ 0.01,
and \ 0.05 vs. hypertensives). Conclusions Although
hypertensives have significantly higher coronary calci-
fications, sensitivity and specificity are comparably high
as in normotensives. The prevalence of CAD is higher in
hypertensives and brings about a trend towards a lower
NPV and a higher PPV.
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Abbreviations
CAD Coronary artery disease
CTCA Computed tomography coronary angiography
CCA Conventional coronary angiography
Introduction
Computed tomography coronary angiography (CTCA)
has been shown to reliably detect coronary artery
disease (CAD) [1–12]. As a non-invasive tool its
clinical role has been outlined to obviate the need for
conventional coronary angiography (CCA) in patients
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with a low to intermediate pre-test probability, whose
symptoms, inconclusive electrocardiograms or equiv-
ocal stress tests require specific testing [13–15].
Hypertensive patients are more prone to CAD as
compared with normotensive patients [16, 17] and an
aggravating effect of hypertension on the progression
of arterial wall calcification has been well established
in several studies [18–20]. Coronary calcifications,
however, may often cause blooming artefacts in
CTCA, leading to overestimation of lesion severity
[21]. This may lead to false positive ratings, resulting
in lower specificity and positive predictive value
(PPV).
The purpose of this study was to prospectively
determine the diagnostic accuracy of 64-slice CTCA
in patients with unknown CAD and compare groups
of patients with and without hypertension.
Methods
Patients
Eighty-five consecutive patients (38 women, 47 men;
mean age 64.4 ± 9.4 years; age range 39–82 years)
scheduled for CCA were prospectively enrolled and
underwent an additional CTCA if none of the
following exclusion criteria were present: hypersen-
sitivity to iodinated contrast agent, renal insufficiency
(creatinine levels[150 lmol/l), non-sinus rhythm, or
hemodynamic instability. Patients were referred due
to suspected CAD based on symptoms such as
dyspnoe (n = 20), typical angina pectoris (n = 31),
atypical chest pain (n = 18), or to preoperatively rule
out CAD (n = 16). They were categorized in groups
with and without hypertension, with hypertension
defined as systolic blood pressure C140 mmHg and/
or diastolic blood pressure C90 mmHg [22], and/or
patients with known arterial hypertension currently
normotensive at antihypertensive medication.
The study protocol was approved by the local
ethics committee and written informed consent was
obtained from all patients.
CT data acquisition and post-processing
All CT examinations were performed on a 64-slice CT
scanner (Somatom Sensation 64, Siemens Medical
Solutions, Forchheim, Germany). CT scans were
performed during inspiration at breath hold using the
following scanning parameters: detector collimation
of 32 9 0.6 mm, slice acquisition 64 9 0.6 mm by
means of a z-flying focal spot, pitch of 0.2, gantry
rotation time 330 ms, tube voltage of 120 kV and an
effective tube-current time product of 650 mAs
(CTCA) and 60 mAs (calcium scoring). All patients
received a single dose of 2.5 mg isosorbiddinitrate
sublingual (Isoket, Schwarz Pharma, Monheim, Ger-
many) 2 min prior to the scan. In addition, intravenous
metoprolol (5–20 mg) (Beloc, AstraZeneca, London,
UK) was administered prior to the CTCA examination
to achieve a target heart rate \70 beats per minute
(bpm), if necessary. For CTCA, 80 ml of iodixanol
(Visipaque 320, 320 mg/ml, GE Heathcare, Bucking-
hamshire, UK) at a flow rate of 5 ml/s followed by
30 ml saline solution was injected into an antecubital
vein via an 18-gauge catheter. Bolus tracking was
performed with a region of interest placed into the
ascending aorta, and image acquisition was automat-
ically started 5 s after the signal density reached a
predefined threshold of 100 Hounsfield units.
CT image reconstruction and analysis
Non-enhanced CT were reconstructed at 60% of the
R-R interval using non-overlapping slices (thickness
3.0 mm; reconstruction kernel B35). Contrast-
enhanced CT angiograms were retrospectively recon-
structed throughout the entire cardiac cycle in 5%
steps of the R-R interval. CTCA images were
reconstructed with a slice thickness of 1.0 mm and
an increment of 0.8 mm, using a medium-soft and a
sharp tissue convolution kernel (B30f). In case of
vessel wall calcifications, additional images were
reconstructed using a sharp-tissue convolution kernel
(B46) and preferably analyzed using a bone window
setting (window width: 1500 HU; window level:
500 HU) to compensate for blooming artifacts. All
images were transferred to an external workstation
(Leonardo, Siemens Medical Solutions).
Calcifications were quantified with dedicated
scoring software (Syngo CaScore, Siemens Medical
Solutions) using the Agatston method [23].
For analysis of CTCA data, coronary arteries were
segmented as suggested by the American Heart
Association [24]: The right coronary artery (RCA)
was defined to include segments 1–4, the left main
artery (LM) and the left anterior descending artery
764 Int J Cardiovasc Imaging (2008) 24:763–770
123
(LAD) to include segments 5–10, and the left
circumflex artery (CX) to include segments 11–15.
The intermedial artery was designated as segment 16,
if present. All segments with a diameter of at least
1.5 mm at their origin were included.
First, one reader semi-quantitatively assessed the
overall image quality in the best reconstruction
interval on a 5-point scale, based on a previously
published score [25, 26] (1, no artifacts; 2, mild
artifacts; 3, moderate artifacts; 4, severe artifacts; 5
non-evaluative), and determined the reconstruction
interval with the best image quality. Images in the best
reconstruction interval were evaluated and classified
by two independent readers using axial source images,
multi-planar reformations, and thin-slab maximum
intensity projections on a per-segment basis. Both
readers visually assessed all coronary artery segments
for the presence of significant stenoses, defined as
narrowing of the coronary luminal diameter C50%.
For any disagreement in data analysis between the two
observers, consensus agreement was achieved. Diag-
nostic accuracy of CTCA was determined on an
‘‘intention-to-diagnose’’-basis; no coronary segment
was excluded; non-evaluative segments were rated as
stenosed, as previously suggested [27].
Conventional coronary angiography
CCA was performed according to standard tech-
niques and multiple views were recorded for further
analysis. The angiograms were evaluated by two
experienced observers who were aware of the
patients’ clinical history but blinded to the results
from CTCA. Coronary artery segments were defined
as mentioned above [24], and analysis was performed
in all vessels with a luminal diameter of at least
1.5 mm, excluding those vessels distal to complete
occlusions. Each vessel segment was scored as being
significantly stenosed, defined as a diameter reduc-
tion of C50%.
Statistical analysis
Quantitative variables were expressed as mean ± stan-
dard deviation and categorical variables as frequencies,
median (25th, 75th percentiles), or percentages.
Kappa statistics were calculated for inter-observer
agreements for assessment of significant coronary
artery (patient-, vessel-, and segment-based) stenoses.
Sensitivity, specificity, PPV, negative predictive
value (NPV) and accuracy in the identification of
stenoses were assessed on a per-segment, per-vessel,
and per-patient basis by using cross tables. CCA was
considered the standard of reference.
Differences between the two groups regarding
diagnostic performance were tested for significance
by using v2-tests for comparison of cross tables. For
further comparison, Student’s t-tests for independent
samples were performed for the variables: age, heart
rate, heart rate variability, blood pressure and body
mass index (BMI). Mann–Whitney-U-tests were
performed for image quality, best reconstruction
interval, and calcium-score. v2-tests were performed
for gender, symptoms, diabetes, smoking, dyslipide-
mia, prevalence of CAD, and true positive, true
negative, false positive and false negative findings. A
P-value of \0.05 was considered to indicate statis-
tical significance. SPSS software (SPSS 15.0,
Chicago, ILL, USA) was used for statistical testing.
Results
CCA and CTCA were successfully performed in all
85 patients within 8 ± 16 days. The study population
consisted of 59 hypertensive (69%) and 26 normo-
tensive patients (31%). As a consequence of the study
design blood pressure was significantly higher in
hypertensives than in normotensives, despite antihy-
pertensive treatment (Table 1). Forty-one patients
(48%) were on oral beta-adrenoreceptor antagonist
medication as part of their anti-hypertensive medica-
tion, additional intravenous metoprolol prior to the
CT examination was administered in 7 (8%) patients.
Baseline characteristics of the entire study population
and within both groups are given in Table 1; notably,
the coronary calcium-score was significantly higher
in the group of hypertensive patients, as compared to
normotensive patients, while gender, age, BMI, and
overall image quality did not differ.
In 85 patients, a total of 339 vessels (1 missing left
main artery) and 1151 coronary artery segments with
a diameter C1.5 mm were evaluated (of the 209
missing segments 135 were missing due to anatom-
ical variants and 74 had a diameter less than 1.5 mm
at their origin). Thirteen segments (1.1%) were rated
not evaluative in CTCA due to motion artifacts and
were subsequently scored as ‘‘false positive’’ on an
Int J Cardiovasc Imaging (2008) 24:763–770 765
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intention-to-diagnose-basis; i.e. 3/798 segments
(0.4%) in the hypertensive group of patients and
10/353 segments (2.8%) in the normotensive group.
Diagnostic performance of CTCA
A total of 112 coronary artery stenoses with a
diameter narrowing of more than 50% in diameter
were identified with CCA in 42/85 patients (49%).
Coronary artery stenosis was most often found in the
LAD (29/85; 34%) and the CX (29/85; 34%),
followed by the RCA (23/85; 27%), and the LM
(1/84; 1%). Single-vessel disease was present in
16/85 (19%), 2-vessel disease in 13/85 (15%), and
3-vessel disease in 13/85 (15%). Significant CAD
was excluded in 43/85 patients (51%). The preva-
lence of CAD was significantly higher in the group of
hypertensive patients (59% vs. 27%, P \ 0.01)
(Table 2).
Kappa values for inter-observer agreement for
coronary artery stenosis detection with CTCA were
0.91, 0.69, and 0.57 (patient-, vessel-, and segment-
based) indicating a moderate to excellent agreement.
The patient-based analysis revealed that CTCA
correctly ruled out CAD in 35/43 (81%) patients
(hypertensive patients (HP) 20/24, 83%; normoten-
sive patients (NP) 15/19, 79%; with a no significant
difference between the groups: P = 0.72) and cor-
rectly identified patients with significant stenosis in
39/42 (93%) patients (HP 32/35, 91%; NP 7/7, 100%;
P = 0.42). Eight of 43 (19%) patients without CAD
(HP 4/24, 17%; NP 4/19, 21%; P = 0.72) were
falsely rated to have CAD and 3/42 (7%) patients
with CAD (HP 3/35, 9%; NP 0/7, 0%; P \ 0.42)
were falsely rated to have no CAD.
The overall diagnostic performance of CTCA, and
within both groups on a patient-, vessel-, and
segment-based analysis is presented in Table 2 and
Table 1 Patient demographics
All patients Hypertensive patients Normotensive
patients
Significance
(P=)
Number of patients (n) 85 59 26
Female/male (n) 38/47 28/31 10/16 0.44
Age (years) 64.4 ± 9.4 (39–82) 65.3 ± 8.6 (49–82) 62.2 ± 10.9 (39–77) 0.16
BMI (kg/m2) 23.1 ± 4.0
(13.3–35.8)
23.1 ± 3.9
(14.2–34.0)
23.3 ± 4.5
(13.3–35.8)
0.86
Dyslipidemia (n) 35 28 7 0.08
Diabetes (n) 15 12 3 0.33
Smoking (n) 36 26 10 0.63
Systolic BP (mmHg) 136 ± 19 (100–190) 142 ± 18 (100–190) 122 ± 12 (101–139) \0.001
Diastolic BP (mmHg) 79 ± 12 (45–110) 83 ± 10 (63–110) 70 ± 10 (45–86) \0.001
No symptoms (n) 16 9 7 0.21
Typical angina pectoris (n) 31 22 9 0.70
Atypical chest pain (n) 19 13 5 0.77
Dyspnoea (n) 20 15 5 0.54
HR at CTCA (bpm) 63.3 ± 9.1 (46–90) 63.1 ± 9.7 (46–90) 63.8 ± 7.9 (48–76) 0.78
HR variability at CTCA (bpm) 4.3 ± 4.4 (0.5–22.2) 4.6 ± 4.8 (0.8–22.2) 3.7 ± 3.3 (0.5–14.8) 0.39
Best CTCA recon. interval
30,35,40,55,60,65,70%
60 (60,70)
5,7,3,3,41,19,7
60 (60,70)
4,6,3,2,28,12,4
60 (60,70)
1,1,0,1,13,7,3
0.13
Overall CTCA image quality score
1,2,3,4,5
2 (1,4) 30,30,17,8,0 2 (1,4) 19,22,13,5,0 2 (1,4) 11,8,4,3,0 0.53
Coronary calcifications (n) 68 49 19 0.29
Coronary calcium-score 156 (5,1908) 256 (45,1908) 69 (0,1025) \0.05
Quantitative variables are expressed as mean ± standard deviation (range); categorical variables are expressed as frequencies, or
median (25th, 75th percentiles); BMI: body mass index; BP: blood pressure; CTCA: computed tomography coronary angiography;
HR: heart rate; recon.: reconstruction
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Fig. 1. There are trends towards a higher PPV
(P = 0.05) and a lower NPV (P = 0.15) in hyper-
tensive patients as compared to normotensive
patients. Sensitivity and specificity do not differ
between both groups.
Discussion
The present study is the first to establish the value of
64-slice CT to assess CAD in hypertensive patients.
The results demonstrate that although hypertensives
have significantly higher coronary calcifications,
which may impair diagnostic accuracy of CTCA
[3], sensitivity and specificity do not differ compared
to normotensives. Furthermore, as prevalence of
CAD is higher in hypertensives, a trend towards a
higher PPV and a lower NPV is documented in this
patient group.
The fact, that hypertension is a major risk factor for
CAD [16, 17] is fully in line with the results of our
study population, showing that the prevalence of CAD
in hypertensive patients is significantly higher com-
pared to normotensive patients. It is also known, that
the prevalence of a disease affects the diagnostic
performance of a test, in a way that the PPV increases
and the NPV decreases when the prevalence increase,
while sensitivity and specificity are generally not
affected (Bayesian theorem). With CTCA the Bayes-
ian theorem can be easily followed with our results and
the results of previous CTCA studies: So far the study
population with the highest prevalence of CAD was
presented by Ehara et al. [8] with 88%, while the
patient population with the lowest prevalence was
presented by Ropers et al. [9] (31%). The PPV was
98% by Ehara et al. and 83% by Ropers et al. [9],
comparable to the high PPV in our hypertensive group
(PPV: 89%; prevalence 59%) and the lower PPV in
Table 2 Diagnostic accuracy of CTCA
All patients Hypertensive patients Normotensive patients Significance
(P=)
Number of patients 85 59 26
Number of vessels 339 236 103
Number of segments 1151 798 353
Prevalence of CAD
(one-, two-, three-vessel)
42 (16, 13, 13) 35 (14, 12, 9) 7 (2, 1, 4) \0.01 (0.08, 0.05, 0.98)
Patient-based analysis
Sensitivity 92.9% (80.5–98.5) 91.4% (76.9–98.2) 100% (NA) 0.42
Specificity 81.4% (66.6–94.6) 83.3% (62.6–95.3) 78.9% (54.4–93.9) 0.71
PPV 82.9% (69.2–92.4) 88.9% (73.9–96.9) 63.6% (30.8–89.1) 0.05
NPV 92.1% (78.6–98.3) 86.9% (66.4–97.2) 100% (NA) 0.15
Accuracy 87.1% (78.0–93.4) 88.1% (77.1–95.1) 84.6% (65.1–95.6) 0.66
Vessel-based analysis
Sensitivity 90.2% (81.7–95.7) 89.2% (79.1–95.6) 94.1% (71.3–99.9) 0.55
Specificity 92.6% (88.7–95.5) 92.4% (87.4–95.9) 93.0% (85.4–97.4) 0.86
PPV 79.6% (69.9–87.2) 81.7% (70.7–89.9) 72.7% (49.8–89.3) 0.36
NPV 96.8% (93.7–98.6) 95.8% (91.5–98.3) 98.8% (93.3–99.9) 0.21
Accuracy 92.0% (88.6–94.7) 91.5% (87.2–94.8) 93.2% (86.5–97.2) 0.60
Segment-based analysis
Sensitivity 80.4% (71.8–87.3) 81.6% (71.9–89.1) 76.0% (54.9–90.6) 0.53
Specificity 96.2% (96.2–97.2) 95.8% (94.0–97.1) 96.9% (94.4–98.5) 0.36
PPV 69.2% (60.5–77.0) 70.3% (60.4–78.9) 65.5% (45.7–82.1) 0.62
NPV 97.9% (96.8–98.6) 97.7% (96.3–98.7) 98.1% (96.0–99.3) 0.65
Accuracy 94.6% (93.2–95.9) 94.2% (92.4–95.8) 95.4% (92.7–97.4) 0.39
Values for diagnostic accuracy in parentheses represent 95% confidence intervals; CAD: coronary artery disease; NA: not available;
NS: not significant; NPV: negative predictive value; PPV: positive predictive value
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our normotensive group (PPV: 64%; prevalence 27%).
Again fully in line with the Bayesian theorem, the
NPV was lower in the high prevalence study [8] as
compared to the low prevalence study [9] (86% vs.
98%), and similarly, lower in our hypertensive group
than in our normotensive group (87% vs. 100%).
Hypertension is associated with a progression of
arterial wall calcification [18–20], which was under-
lined by a significantly higher coronary calcium-score
in our hypertensive patient group. As coronary
calcifications have been suspected to lead to blooming
artefacts and subsequent overestimations of lesions
with false positive ratings and lower specificity in
CTCA [21], Raff et al. [3] found sensitivity of CTCA
to increase with increasing calcium-score and speci-
ficity to decrease with increasing calcium-score. In
order to compensate this shortcoming of CTCA the
use of a sharp tissue-convolution kernel for the
assessment of calcified coronary lesions has been
introduced [28], to reduce the blooming artifacts that
occur at the edges of calcified plaques; however a
significant increase in image noise has to be accepted
with the use of a sharp kernel [29]. In the present study
we have evaluated all calcified lesions with a sharp-
tissue convolution kernel, and no differences in
sensitivity and specificity were found between the
hypertensive patients with a high calcium-load and the
normotensive patients with a low calcium-load
(Fig. 2). Therefore, we believe that the use of a sharp
tissue convolution kernel for the evaluation of calci-
fied lesions can be considered adequate. Our values are
therefore not comparable to those by Schuijf et al.
[30], who evaluated the diagnostic performance of 4-
and 16-slice CT in hypertensive patients.
Study limitations
v2-tests for comparison of diagnostic performance on
a per-vessel and per-segment-basis must be regarded
as an approximation because of data clustering.
However, adequate statistical testing could not be
applied because of small group sizes, and therefore
further studies with larger patient populations are
required to confirm the results of our study.
Furthermore, the blinded separate analysis of CCA
and CTCA may have affected the agreement on a
segment based analysis, as assignment of segments
may have introduced a subjectivity bias. However,
high kappa values indicate an excellent inter-observer
agreement on the clinically per patient level.
Finally, our study was performed using 64-slice
CT and not using most recent dual-source CT scanner
technology [11].
Perspectives
The amount of false positive and false negative
ratings by CTCA is low in hypertensives and does not
Fig. 1 Sensitivity, specificity, negative predictive value
(NPV), positive predictive value (PPV), and accuracy of
CTCA in comparison to the reference standard CCA for the
detection of significant coronary artery disease in hypertensive
and normotensive patients on a patient- (a), vessel- (b), and
segment-based analysis (c)
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significantly differ to normotensive patients, despite
more calcifications in hypertensives. CTCA is a
useful tool to accurately rule out CAD in hyperten-
sives and should therefore be considered as a valuable
non-invasive alternative to prevent unnecessary CCA
in this population.
Conclusion
Although hypertensives have significantly higher
coronary calcifications, sensitivity and specificity
are comparably high as in normotensives. The
prevalence of CAD is higher in hypertensives and
brings about a trend towards a lower NPV and a
higher PPV.
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